MInimizing Delirium With Nasal Dexmedetomidine-InducEd Sleep (MIDDIES)

The trial registration documents a new Phase 2 interventional study on ClinicalTrials.gov evaluating intranasal dexmedetomidine as a potential treatment for preventing postoperative delirium in surgical patients. The study will enroll participants receiving either dexmedetomidine or placebo as nighttime interventions. This is an informational registry entry without direct compliance obligations.

Healthcare providers and clinical investigators should note this trial if involved in perioperative care or delirium research. Patients scheduled for major abdominal surgery at participating sites may be eligible for enrollment consideration.